Vacirca Jeff L
- SEC CIK
- 0001724161
In the past year, 1 open-market purchase filing worth $501.5K and no sales.
Current role at each company
- CAI Caris Life Sciences, Inc.Directoras of Aug 14, 2026
- ASRT Assertio Holdings, Inc.Directoras of Jun 12, 2024
- SPPI Spectrum Pharmaceuticals IncDirectoras of Aug 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $501.5K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$501.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vacirca Jeff L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAI Caris Life Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 (view filing) | May 11 | 1 day | Vacirca Jeff LDirector | PPurchase | +31.1K | $16.15 | +$501.5K | +166.7%49.7K after |
ASRT Assertio Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 (view filing) | Jun 11 | 1 day | Vacirca Jeff LDirector | PPurchase | +10.0K | $1.11 | +$11.1K | +7.1%151.2K after |
SPPI Spectrum Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 (view filing)8:17 PM ET | Nov 30 | 2 days | Vacirca Jeff LDirector | PPurchaseCommon Stock, $0.001 par value | +50.0K | $0.45 | +$22.5K | +22.7%270.2K after |